THE SAFETY OF ANTICOAGULATION FOR ATRIAL FIBRILLATION WITH DOAC VERSUS WARFARIN IN PATIENTS WITH VARIOUS STAGES OF RENAL FUNCTION

The safety and efficacy of direct-oral anticoagulants (DOAC) compared with warfarin in patients with varying levels of chronic kidney disease (CKD) have not been well studied and continues to be debated. We included patients who were >18 years old who had non-valvular atrial fibrillation and